Cargando…
The comprehensive expression and functional analysis of m6A modification “readers” in hepatocellular carcinoma
N6-methyladenosine (m6A) modification regulators are essential for the diagnosis and treatment of various cancers. However, the comprehensive analysis about roles of m6A “readers” in hepatocellular carcinoma (HCC) remains unclear. UALCAN, GEPIA2, HPA, Kaplan Meier plotter, cBioPortal, STRING WebGest...
Autores principales: | Qin, Sha, Liu, Gaoming, Jin, Haoer, Chen, Xue, He, Jiang, Xiao, Juxiong, Qin, Yan, Mao, Yitao, Zhao, Luqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417225/ https://www.ncbi.nlm.nih.gov/pubmed/35963644 http://dx.doi.org/10.18632/aging.204217 |
Ejemplares similares
-
The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma
por: Qin, Sha, et al.
Publicado: (2022) -
The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma
por: Qin, Sha, et al.
Publicado: (2021) -
New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials
por: Jin, Haoer, et al.
Publicado: (2022) -
Systematic pan-cancer analysis identifies RALA as a tumor targeting immune therapeutic and prognostic marker
por: Jin, Haoer, et al.
Publicado: (2022) -
The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications
por: Qin, Sha, et al.
Publicado: (2021)